FDA Documents of Bayer Pharma AG

Bayer Pharma AG is an organization that has been audited by the FDA 53 times between 2000 and 2019 across all 14 sites.

Documents

FDA 483 Bayer Pharma AG, Leverkusen | 2019

Out-of-stock
Issued on: Mar 22, 2019
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2017

Out-of-stock
Issued on: Jul 3, 2017
Human Drug Form 483

FDA 483 Bayer Pharma AG, Leverkusen | 2017

Out-of-stock
Issued on: Jan 20, 2017
Human Drug Form 483

FDA 483 Bayer Pharma AG, Leverkusen | 2014

Out-of-stock
Issued on: Nov 14, 2014
Human Drug Form 483

FDA 483 Bayer Pharma AG, Leverkusen | 2014

Out-of-stock
Issued on: Nov 14, 2014
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2014

Out-of-stock
Issued on: May 13, 2014
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2014

Out-of-stock
Issued on: May 13, 2014
Human Drug Form 483

FDA 483 Bayer Pharma AG, Bergkamen | 2013

Out-of-stock
Issued on: May 24, 2013
Human Drug Form 483

FDA 483 Bayer Pharma AG, Bergkamen | 2013

Out-of-stock
Issued on: May 24, 2013
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2012

Out-of-stock
Issued on: Sep 18, 2012
Human Drug Form 483

FDA 483 Bayer Pharma AG, Leverkusen | 2012

Out-of-stock
Issued on: Jul 9, 2012
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2010

Out-of-stock
Issued on: May 27, 2010
Human Drug Form 483

FDA 483 Bayer Pharma AG, Wuppertal | 2010

Out-of-stock
Issued on: May 27, 2010
Human Drug Form 483

FDA 483 Bayer Pharma AG, Leverkusen | 2010

Out-of-stock
Issued on: Feb 23, 2010
Human Drug Form 483

FDA 483 Bayer Pharma AG, Bergkamen | 2009

Out-of-stock
Issued on: Mar 10, 2009
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2008

Out-of-stock
Issued on: Apr 24, 2008
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2006

Out-of-stock
Issued on: Dec 7, 2006
Human Drug Form 483

FDA 483 Bayer Pharma AG, Berlin | 2004

Out-of-stock
Issued on: Oct 22, 2004
Human Drug Form 483

FDA 483 Bayer Pharma AG, Bergkamen | 2004

Out-of-stock
Issued on: Feb 20, 2004
Human Drug Form 483

FDA Investigators(49)